{
  "meta": {
    "title": "Chronic_Myeloid_Leukemia",
    "url": "https://brainandscalpel.vercel.app/chronic-myeloid-leukemia-01363204.html",
    "scrapedAt": "2025-11-29T18:32:00.284Z"
  },
  "questions": [
    {
      "id": 15369,
      "choices": [
        {
          "id": 61436,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (9; 22) </span></span></p>"
        },
        {
          "id": 61437,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (15; 17) </span></span></p>"
        },
        {
          "id": 61438,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8; 14) </span></span></p>"
        },
        {
          "id": 61439,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8; 21) </span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly male with dragging sensation in abdomen presents in the OPD. His cell count had elevated total leucocyte count and increased platelet count. His peripheral smear shows metamyelocytes, myelocytes, eosinophilia and basophilia (image given for reference). Which of the following is the likely genetic anomaly present in this individual? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture7_WdmXOwZ.jpg\" style=\"height:194px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6747004",
      "question_audio": null,
      "question_video": null,
      "map_id": 32031,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. t (9; 22)</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> increased cell count (leucocytes and platelets) </strong>with peripheral smear showing <strong>metamyelocytes, myelocytes, eosinophilia and basophilia (mixed myeloid lineage) </strong>is suggestive of a diagnosis of <strong>chronic myeloid leukemia</strong>. Two other features also fit in the diagnosis: </span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of the patient (peak incidence in 5/6th decade of life) </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The dragging sensation (can be due to splenomegaly seen in CML patients) </span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: t (15;17)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with<strong> acute promyelocytic leukemia (APL).</strong> It involves the fusion of the<strong> PML (promyelocytic</strong> <strong>leukemia) gene on chromosome 15 with the RARA (retinoic acid receptor alpha) gene on chromosome 17</strong>, resulting in the <strong>PML-RARA fusion gene.</strong> This fusion gene plays a crucial role in the pathogenesis of APL.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: t (8;14)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>Burkitt&#39;s lymphoma.</strong> It involves the<strong> c-MYC gene on chromosome 8 </strong>and the <strong>immunoglobulin</strong> <strong>heavy chain gene on chromosome 14</strong>. The dysregulation of <strong>c-MYC</strong>, a proto-oncogene, contributes to the <strong>rapid and uncontrolled</strong> <strong>proliferation of B cells</strong> in Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: t (8;21)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>acute myeloid leukemia (AML)</strong>, particularly the subtype known as <strong>AML with t(8;21), </strong>also called <strong>AML-M2. </strong>It involves the fusion of the <strong>AML1 (acute myeloid leukemia 1) gene on chromosome 21 with the ETO (eight-twenty-one) gene on chromosome 8, </strong>resulting in the <strong>AML1-ETO fusion gene.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> genetic anomaly </strong>likely present in an <strong>elderly male </strong>with an<strong> elevated leukocyte and platelet count</strong>, peripheral smear showing <strong>metamyelocytes, myelocytes, eosinophilia, and basophilia is t (9;22), </strong>which is associated with <strong>chronic myeloid leukemia (CML).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p622) </span></span></em></strong></p>",
      "correct_choice_id": 61436,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15329,
      "choices": [
        {
          "id": 61276,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myeloid leukemia </span></span></span></p>"
        },
        {
          "id": 61277,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute lymphoblastic leukemia </span></span></span></p>"
        },
        {
          "id": 61278,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic myelogenous leukemia </span></span></span></p>"
        },
        {
          "id": 61279,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myelodysplastic syndrome </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A peripheral smear with increased neutrophils, basophils, eosinophils, and platelets is highly suggestive of:</span></span></span></p>",
      "unique_key": "Q2152030",
      "question_audio": null,
      "question_video": null,
      "map_id": 32030,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Chronic myelogenous leukemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic Myelogenous Leukemia (CML):</strong> is characterized by the presence of the<strong> Philadelphia chromosome</strong>, resulting in the constitutive activation of the <strong>BCR-ABL1 tyrosine kinase</strong>. This leads to<strong> increased production of myeloid cells,</strong> including <strong>neutrophils,</strong> <strong>basophils, eosinophils, and platelets.</strong> The peripheral smear in CML often shows a <strong>&quot;left-shift,&quot; </strong>with <strong>increased mature and immature myeloid cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Acute Myeloid Leukemia (AML):</strong> is characterized by the <strong>rapid growth </strong>of <strong>abnormal myeloid cells </strong>in the bone marrow. While AML may show <strong>increased myeloid cells </strong>in the peripheral smear, it typically presents with<strong> blasts and a decrease in mature cells</strong>, unlike the broad spectrum of increased cells seen in the question.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Acute Lymphoblastic Leukemia (ALL):</strong> <strong>primarily affects lymphoid cells</strong>. It is characterized by the presence of <strong>lymphoblasts </strong>in the peripheral blood. The question describes an increase in myeloid cell lineages (neutrophils, basophils, eosinophils, and platelets), making ALL less likely.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Myelodysplastic Syndrome (MDS):</strong> is a<strong> group of disorders </strong>characterized by <strong>ineffective hematopoiesis</strong>. While MDS can present with<strong> cytopenias and dysplastic </strong>changes in blood cells, the specific pattern described in the question (increased neutrophils, basophils, eosinophils, and platelets) is more indicative of CML.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic myeloid leukemia </strong>is a<strong> stem cell disease</strong> that is characterized by <strong><em>leukocytosis with granulocytic immaturities, basophilia, splenomegaly</em></strong> and distinct chromosomal abnormality<strong> Philadelphia chromosome</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 622) </span></span></em></strong></p>",
      "correct_choice_id": 61278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15374,
      "choices": [
        {
          "id": 61456,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Whole body PET CT </span></span></p>"
        },
        {
          "id": 61457,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucocyte alkaline phosphatase </span></span></p>"
        },
        {
          "id": 61458,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immunophenotyping</span></span></p>"
        },
        {
          "id": 61459,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FISH in the peripheral blood smear </span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A male patient with splenomegaly with myeloid hyperplasia. What&rsquo;s is the next best investigation to be done?</span></span></span></p>",
      "unique_key": "Q2640566",
      "question_audio": null,
      "question_video": null,
      "map_id": 32032,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. FISH in the peripheral blood smear</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fluorescence in situ hybridization (FISH) </strong>is a <strong>molecular cytogenetic </strong>technique that can be applied to detect <strong>specific genetic abnormalities </strong>and is invaluable for diagnosis of <strong>CML </strong>(more likely from the history given in the question). </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Whole-body<strong> PET CT (Positron Emission Tomography with Computed Tomography) </strong>is a valuable imaging tool, particularly in the evaluation of <strong>lymphomas and solid tumors. </strong>However, it may <strong>not be the first-line investigation for myeloid hyperplasia </strong>or diseases<strong> primarily </strong>involving the <strong>bone marrow.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Leucocyte alkaline phosphatase (LAP) </strong>is an <strong>enzyme </strong>that can be measured <strong>to assess the activity of neutrophils</strong>. <strong>Low LAP </strong>scores may be associated with conditions like<strong> chronic myeloid leukemia (CML). </strong>However, this test alone might not provide a <strong>definitive diagnosis </strong>and is often used in conjunction with other tests.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Immunophenotyping </strong>is a crucial investigation in the context of<strong> hematological disorders</strong>. It involves the analysis of <strong>cell surface markers </strong>on <strong>blood or bone marrow cells </strong>but is more useful for other leukemias like <strong>ALL, AML or CLL. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a <strong>male </strong>patient with<strong> splenomegaly and myeloid hyperplasia</strong>, the next best investigation is <strong>Fluorescence in situ hybridization (FISH) </strong>in the peripheral blood smear, particularly to detect chromosomal abnormalities such as the<strong> Philadelphia chromosome </strong>in <strong>chronic myeloid leukemia (CML).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p482) </span></span></em></strong></span></span></span></p>",
      "correct_choice_id": 61459,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}